Department of Surgery, University of Louisville, Louisville, KY.
JSLS. 2020 Oct-Dec;24(4). doi: 10.4293/JSLS.2020.00059.
Outcomes after laparoscopic gastropexy (LG), performed as an alternative to formal paraesophageal hernia (PEH) repair in patients with giant PEH, have been rarely studied. This manuscript evaluates complications and long-term quality-of-life after LG.
An IRB-approved protocol was used to identify patients who underwent LG to alleviate symptoms of acute or chronic gastric obstruction secondary to a paraesophageal hernia. Postoperative outcomes and quality-of-life data were retrospectively collected via chart review and prospectively via phone interview.
Twenty-six patients underwent LG, with a median age of 76 (52 - 91). Median follow-up was 28 (3 to 55) months. Gastropexy was the chosen intervention due to comorbid conditions (23, 88%), gastric inflammation (2, 8%), or intraoperative instability (1, 4%). Nine (35%) suffered postoperative complications, and 2 (8%) required reoperation. At the time of follow-up, 7 (27%) had died, 3 (11%) could not be reached. Sixteen (62%) completed the follow-up survey. Fourteen (88%) reported symptom resolution. Ten (62%) still required antireflux medication. Median Gastroesophageal Reflux Disease-Health Related Quality of Life score was 4.5 (0 to 19). Fourteen (88%) denied current dietary restrictions. All reported satisfaction with the operation.
Laparoscopic PEH repair remains the standard of care for the management of giant PEH. However, a subcategory of patients with high operative risk could be candidates for a shorter operative intervention. As our data infers, LG is a reasonable alternative in this patient population. While the continued use of antisecretory medications is sometimes required, LG restores the ability to tolerate full meals without restrictions and results in excellent patient satisfaction.
腹腔镜胃固定术(LG)已被用于治疗巨大食管裂孔疝(PEH)患者,作为替代正式的食管裂孔疝修补术,其术后结果鲜有研究。本研究评估了 LG 术后的并发症和长期生活质量。
本研究经机构审查委员会批准,通过病历回顾收集接受 LG 以缓解因食管裂孔疝引起的急性或慢性胃梗阻症状患者的术后结果和生活质量数据。
26 例患者接受了 LG,中位年龄为 76 岁(52-91 岁)。中位随访时间为 28 个月(3-55 个月)。LG 被选为干预措施的原因是并存疾病(23 例,88%)、胃炎症(2 例,8%)或术中不稳定(1 例,4%)。9 例(35%)患者发生术后并发症,2 例(8%)需要再次手术。随访时,7 例(27%)患者死亡,3 例(11%)无法联系。16 例(62%)完成了随访调查。14 例(88%)报告症状缓解。10 例(62%)仍需服用抗反流药物。中位胃食管反流病健康相关生活质量评分 4.5 分(0-19 分)。14 例(88%)否认存在当前饮食限制。所有患者均对手术表示满意。
腹腔镜 PEH 修复仍然是治疗巨大 PEH 的标准方法。然而,对于手术风险较高的患者亚组,可选择较短的手术干预。根据我们的数据推断,LG 是此类患者的合理选择。尽管有时需要继续使用抗分泌药物,但 LG 可恢复患者正常进食且无需限制的能力,并获得极佳的患者满意度。